Literature DB >> 31198573

When abdominal pain knocks the door: an unusual presentation of chronic lymphocytic leukemia.

Digdem Ozer Etik1, Nuretdin Suna1, Pelin Borcek2, Fatih Hilmioglu1.   

Abstract

A 67-year-old man presented non-specific abdominal pain. Polypoid mass at appendiceal orifice in the cecum was found on endoscopic investigation without appendicitis sign. Histopathology elucidated underlying mucosal infiltration that was chronic lymphocytic leukemia. This is an isolated and unusual gastrointestinal involvement of hematologic disorder in an older patient.

Entities:  

Year:  2019        PMID: 31198573      PMCID: PMC6544427          DOI: 10.1093/omcr/omz037

Source DB:  PubMed          Journal:  Oxf Med Case Reports        ISSN: 2053-8855


Introduction

Chronic lymphocytic leukemia (CLL), which accounts for ~25% of adult leukemias, is one of the commonest adult leukemia in the western world [1]. Clinically, this disease is characterized by peripheral blood lymphocytosis, lymphadenopathy, hepatosplenomegaly, autoimmune hemolytic anemia and autoimmune thrombocytopenia [2]. CLL can exhibit extramedullary organ involvement such as the central nervous system and skin [1, 2]. The reports of CLL cases involving infiltration of the gastrointestinal tract are relatively rare in the literature and its incidence, based on autopsy, ranges from 5.7% to 13% in patients with CLL [3]. Herein, we report a case where CLL was incidentally discovered in a 65-year-old man’s appendix orifice in the cecum following colonoscopy, who had no history of CLL prior to the endoscopic procedure.

CASE REPORT

A 67-year-old man, having mild intermittent pain in the right lower quadrant abdomen for 1 month, was admitted to the gastroenterology outpatient clinic. Upon enquiry, he denied any fever, weight loss, night sweat or nausea, vomiting and diarrhea, and his past medical history had only arterial hypertension controlled by calcium channel blocker. The physical examination of his abdomen showed no distention, tenderness, defense or palpable mass, and bowel sounds were observed to be present. Initial laboratory tests demonstrated the following findings: hemoglobin value of 14 gr/L, leukocyte count of 23 000/μL, lymphocyte count of 17 840/μL and platelet count of 256 000/μL, in addition to normal liver and kidney function test results. Mild erythematous gastritis was seen during gastroscopy. A polypoid lesion ~3 × 3 cm dimensions, mildly protruding into the lumen of cecum, completely covering appendix orifice, having normal mucosal surface without ulcer or erythema, was observed in white light and narrow band imaging (Fig. 1A and B). Upon identification of the lesion, biopsy samples were obtained from its edges and center. Histopathologic analysis revealed the infiltration of a uniform population of lymphoid cells that were relevant to CLL. The immunohistochemistry of the specimen indicated that the cells were positive for CD5, CD19, CD20, CD23 and CD4 but negative for CD10, Bcl-6 and Cyclin D1 (Figs 2 and 3). Additionally, there were high levels of lactate dehydrogenase [540 U/L (125–245 U/L)] alongside normal levels of beta-2 microglobulin [1.29 mg/L (0.9–2.6 mg/L)] and immunoglobulin G [1028 mg/dL (700–1600 mg/dL)]. The diagnosis of B-cell CLL was made by peripheral blood flow cytometric analysis. However, the circulating lymphocytes were found to be negative for CD38 antigen, which is a known prognostic indicator of CLL. The computed tomography scan of chest, abdomen and pelvis showed no contrast media passage into appendix due to the closure of its orifice but showed increased cecum wall thickness and paraaortic lymphadenopathy of 13 mm in diameter (Fig. 4). The mediastinal, celiac, retroperitoneal and pelvic lymphadenopathies were not observed. Based on Rai and Binet CLL staging systems, the patient’s disease was classified as Stage 0 and Stage A, respectively. Considering the early stage of this disease, the strategy of ‘wait and see’ was proposed after hematology consultation.
Figure 1

Endoscopic view of polypoid lesion completely covers appendix orifice on white light (A) and narrow band imaging (B).

Figure 2

Abdominal computerized tomography imaging revealed no contrast media passage into the appendix.

Figure 3

Nodular mucosal lymphoid infiltrates in histopathological examination (Hematoxylene and eosin, ×20 original magnification).

Figure 4

Immunohistochemical CD20 positivity (A), CD5 positivity (B) and CD43 positivity (C; ×40 original magnification).

Endoscopic view of polypoid lesion completely covers appendix orifice on white light (A) and narrow band imaging (B). Abdominal computerized tomography imaging revealed no contrast media passage into the appendix. Nodular mucosal lymphoid infiltrates in histopathological examination (Hematoxylene and eosin, ×20 original magnification). Immunohistochemical CD20 positivity (A), CD5 positivity (B) and CD43 positivity (C; ×40 original magnification).

DISCUSSION

CLL originates in the bone marrow and can spread to blood and organs of the hemopoietic system [2]. In intra-abdominal CLL, unifocal or multifocal lymphadenopathy or diffuse soft tissue infiltration throughout the mesentery, retroperitoneum and solid organs might be seen [4]. Numerous enlarged lymph nodes or organ infiltration can lead to liver failure, cholecystitis, peritonitis, pancreatico-biliary obstruction or thrombosis of surrounding mesenteric arteries and veins [5]. In rare cases, the leukemic cells can possibly infiltrate the gastrointestinal tract and cause ulcer, polypoid lesions and clinical pictures mimicking malabsorption disorders or chronic inflammatory bowel disease [6-8]. The GI complications may occur after transformation of CLL to diffuse large B-cell lymphoma (Richter syndrome) [1]. Ratterman et al. [4] earlier complied a comprehensive systematic review of published extramedullary involvement of CLL case reports between the year 1975 and 2012. The involvement of the skin and central nervous system was the most commonly reported extramedullary manifestation that accounted for 33% and 27% of the cases, respectively [4]. There were 26 cases related to gastrointestinal involvement [4]; however, the involvement of appendiceal orifice in the colon, like in our patient, was never mentioned. Several studies have emphasized the unfavorable prognosis of extranodal localizations of lymphoproliferative disease [1, 2]; however, it may depend on the site and the extensity of involvement [1, 2]. A follow-up for 18 months revealed that our patient was still asymptomatic and in the early stage without chemo- and/or immunotherapy. Our case is unique for several reasons; firstly, the abdominal pain that was an initial vague symptom yielded to the diagnosis of CLL in an older patient. Secondly, CLL presented with the involvement of the gastrointestinal tract despite the early stage of the disease. Thirdly, there existed mucosal invasion with malignant lymphocytes in the extranodal organ without transformation to lymphoma. Additionally, gastrointestinal involvement was occult, and it did not cause any ulceration, inflammation and obstruction even though the polypoid lesion closed the appendiceal orifice. The localization and presentation without signs of appendicitis make it a truly noteworthy case. Finally, the hematologists and gastroenterologists must keep in mind the possibility of extramedullary localizations of a lymphoproliferative disease when a geriatric patient complains of abdominal pain.
  8 in total

1.  Endoscopic findings in chronic lymphocytic leukemia.

Authors:  R Gonçalves; R Sousa; A Banhudo; E Pereira; R Pereira; J Castel-Branco Silveira
Journal:  Am J Clin Oncol       Date:  2000-12       Impact factor: 2.339

Review 2.  Extramedullary chronic lymphocytic leukemia: systematic analysis of cases reported between 1975 and 2012.

Authors:  Megan Ratterman; Kimberly Kruczek; Suela Sulo; Tait D Shanafelt; Neil E Kay; Chadi Nabhan
Journal:  Leuk Res       Date:  2013-09-06       Impact factor: 3.156

Review 3.  The Clinical Spectrum of Hepatic Manifestations in Chronic Lymphocytic Leukemia.

Authors:  Natalia Kreiniz; Ofrat Beyar Katz; Aaron Polliack; Tamar Tadmor
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2017-07-23

4.  iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.

Authors:  Michael Hallek; Bruce D Cheson; Daniel Catovsky; Federico Caligaris-Cappio; Guillermo Dighiero; Hartmut Döhner; Peter Hillmen; Michael Keating; Emili Montserrat; Nicholas Chiorazzi; Stephan Stilgenbauer; Kanti R Rai; John C Byrd; Barbara Eichhorst; Susan O'Brien; Tadeusz Robak; John F Seymour; Thomas J Kipps
Journal:  Blood       Date:  2018-03-14       Impact factor: 22.113

Review 5.  Chronic lymphocytic leukaemia.

Authors:  Thomas J Kipps; Freda K Stevenson; Catherine J Wu; Carlo M Croce; Graham Packham; William G Wierda; Susan O'Brien; John Gribben; Kanti Rai
Journal:  Nat Rev Dis Primers       Date:  2017-01-19       Impact factor: 52.329

6.  An autopsy study of 1206 acute and chronic leukemias (1958 to 1982).

Authors:  M Barcos; W Lane; G A Gomez; T Han; A Freeman; H Preisler; E Henderson
Journal:  Cancer       Date:  1987-08-15       Impact factor: 6.860

Review 7.  Chronic lymphocytic leukemia: an unusual cause of upper gastrointestinal hemorrhage.

Authors:  D O Faigel; D J Vaughn; E E Furth; D C Metz
Journal:  Am J Gastroenterol       Date:  1995-04       Impact factor: 10.864

8.  Colonic involvement in a patient with chronic lymphocytic leukaemia.

Authors:  P E T Arkkila; H Nuutinen; F Ebeling; E Elonen; P Kärkkäinen; M-L Karjalainen-Lindsberg
Journal:  Gastroenterol Res Pract       Date:  2008       Impact factor: 2.260

  8 in total
  1 in total

1.  Lymphoepithelioma-Like Gastric Carcinoma and Gastric Involvement of Chronic Lymphocytic Leukemia: Two Rare Identities Coexisting in One Patient.

Authors:  Narcisa Guimaraes; Ines Bolais Monica; Simone Oliveira; Daniela Pato Pais; Sara Andrade; Ines Bertao Colaco; Carlos Vila Nova; Vera Vieira; Nuno Azenha; Joao Fonseca Pinho; Fatima Guedes; Lucilia Conceicao; Jose Valente Cecilio
Journal:  J Med Cases       Date:  2022-01-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.